mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |